Literature DB >> 11074368

Mitochondrial DNA mutations in the pathogenesis of human disease.

P F Chinnery1, D M Turnbull.   

Abstract

The coding sequence for the human mitochondrial genome (mtDNA) was published in 1981. Within a decade, the first pathogenic mtDNA mutations were described in humans with sporadic and maternally inherited disease. The last ten years has seen a profusion of reports describing new pathogenic mutations associated with a diverse range of clinical phenotypes. Although we have seen great advances in our understanding of the molecular mechanisms involved in the pathogenesis of mtDNA disease, we are only just beginning to tackle some of the more difficult questions. In this review we describe recent advances in our understanding of mtDNA disease and highlight ways that this knowledge might lead to novel therapies in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074368     DOI: 10.1016/s1357-4310(00)01805-0

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  18 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 2.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

3.  Germline bottlenecks, biparental inheritance and selection on mitochondrial variants: a two-level selection model.

Authors:  Denis Roze; François Rousset; Yannis Michalakis
Journal:  Genetics       Date:  2005-05-23       Impact factor: 4.562

Review 4.  The causes of mutation accumulation in mitochondrial genomes.

Authors:  Maurine Neiman; Douglas R Taylor
Journal:  Proc Biol Sci       Date:  2009-01-20       Impact factor: 5.349

5.  Deleterious mtDNA mutations are common in mature oocytes.

Authors:  Hong Ma; Tomonari Hayama; Crystal Van Dyken; Hayley Darby; Amy Koski; Yeonmi Lee; Nuria Marti Gutierrez; Satsuki Yamada; Ying Li; Michael Andrews; Riffat Ahmed; Dan Liang; Thanasup Gonmanee; Eunju Kang; Mohammed Nasser; Beth Kempton; John Brigande; Trevor J McGill; Andre Terzic; Paula Amato; Shoukhrat Mitalipov
Journal:  Biol Reprod       Date:  2020-03-13       Impact factor: 4.285

6.  Mitochondrial heteroplasmy and DNA barcoding in Hawaiian Hylaeus (Nesoprosopis) bees (Hymenoptera: Colletidae).

Authors:  Karl N Magnacca; Mark J F Brown
Journal:  BMC Evol Biol       Date:  2010-06-11       Impact factor: 3.260

7.  Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome.

Authors:  Julia Pinsonneault; Wolfgang Sadée
Journal:  AAPS PharmSci       Date:  2003-11-05

Review 8.  DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.

Authors:  U Zekonyte; S R Bacman; C T Moraes
Journal:  J Intern Med       Date:  2020-04-27       Impact factor: 8.989

9.  Decreased aminoacylation in pathology-related mutants of mitochondrial tRNATyr is associated with structural perturbations in tRNA architecture.

Authors:  Luc Bonnefond; Catherine Florentz; Richard Giegé; Joëlle Rudinger-Thirion
Journal:  RNA       Date:  2008-02-11       Impact factor: 4.942

10.  Mitochondrial DNA aberrations of bone marrow cells from patients with aplastic anemia.

Authors:  Hye-Ran Kim; Myung-Geun Shin; Mi-Ji Kim; Hyeoung-Joon Kim; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.